Regeneron Pharmaceuticals (REGN) Tax Rate Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.00 |
| Dec 31, 2025 | 1,292.00 |
| Sep 30, 2025 | 155.00 |
| Jun 30, 2025 | 602.00 |
| Mar 31, 2025 | 406.00 |
| Dec 31, 2024 | -677.00 |
| Sep 30, 2024 | -266.00 |
| Jun 30, 2024 | -204.00 |
| Mar 31, 2024 | -1,860.00 |
| Dec 31, 2023 | 2,028.00 |
| Sep 30, 2023 | 279.00 |
| Jun 30, 2023 | -538.00 |
| Mar 31, 2023 | -1,366.00 |
| Dec 31, 2022 | -5,909.00 |
| Sep 30, 2022 | -1,849.00 |
| Jun 30, 2022 | -1,473.00 |
| Mar 31, 2022 | -3,416.00 |
| Dec 31, 2021 | -1,493.00 |
| Sep 30, 2021 | -1,747.00 |
| Jun 30, 2021 | -1,544.00 |
| Mar 31, 2021 | -3,406.00 |
| Dec 31, 2020 | -2,565.00 |
| Sep 30, 2020 | -3,086.00 |
| Jun 30, 2020 | -3,831.00 |
| Mar 31, 2020 | -6,593.00 |
| Dec 31, 2019 | 36,301.00 |
| Sep 30, 2019 | -4,128.00 |
| Jun 30, 2019 | -3,979.00 |
| Mar 31, 2019 | -4,667.00 |
| Dec 31, 2018 | -7,376.00 |
| Sep 30, 2018 | -3,091.00 |
| Jun 30, 2018 | -2,488.00 |
| Mar 31, 2018 | -1,194.00 |
| Dec 31, 2017 | 31,828.00 |
| Dec 31, 2016 | 2,475.00 |
| Sep 30, 2016 | 2,853.00 |
| Jun 30, 2016 | 3,150.00 |
| Mar 31, 2016 | 4,457.00 |